Eoptal 450 Tablet contains Oxcarbazepine 450 mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy, including partial seizures with or without secondary generalization. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing the propagation of seizure activity through modulation of voltage-sensitive sodium channels. This mechanism helps to restore the normal balance of nerve activity in the brain, thereby preventing seizure episodes. Eoptal 450 is also utilized as adjunctive therapy for certain types of generalized seizures and may be prescribed off-label for neuropathic pain syndromes. The tablet should be administered orally, with dosing individualized based on clinical response and tolerability, typically initiated at a low dose and gradually titrated to minimize adverse effects. Common side effects include dizziness, somnolence, headache, nausea, and hyponatremia, necessitating periodic monitoring of serum sodium levels, especially in elderly patients or those on concomitant diuretics. Caution is advised in patients with hepatic or renal impairment. Eoptal 450 should be used under strict medical supervision, with attention to potential drug interactions, particularly with other antiepileptic agents, oral contraceptives, and CNS depressants. Patient adherence and regular follow-up are essential to optimize therapeutic outcomes and minimize risks.